Telomeres Parameters in Celiac Disease

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02126033

Enrollment

Registered

2014-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2014-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac Disease

Keywords

celiac, telomere, telomerase

Brief summary

Celiac disease is an autoimmune process that causes destructive changes in the epithel of the small bowel and it is also a pre-malignant state (e.g lymphoma). The aim of the study is to examine telomere length and other parameters of genetic instability from peripheral blood lymphocytes of patients with celiac disease compared with healthy controls.

Interventions

PROCEDUREtake blood samples

Study design

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* patients with celiac disease

Exclusion criteria

* known malignancy * cannot sign informed consent * under age 18

Design outcomes

Primary

Measure	Time frame
telomere length	at entry, after 6 months of gluten-free diet

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026